Target type: molecularfunction
Enables the transfer of a oligopeptide from one side of a membrane to the other, up its concentration gradient. The transporter binds the solute and undergoes a series of conformational changes. Transport works equally well in either direction and is driven by proton movement. [GOC:mtg_transport, OMIM:600544]
Proton-dependent oligopeptide secondary active transmembrane transporter activity involves the movement of oligopeptides across cell membranes using the electrochemical gradient of protons (H+) as the driving force. These transporters are integral membrane proteins that typically possess multiple transmembrane domains. They function by coupling the downhill movement of protons down their concentration gradient to the uphill movement of oligopeptides against their concentration gradient. This process is known as secondary active transport, as it indirectly utilizes energy stored in the proton gradient, which is established by primary active transport mechanisms such as ATPases.
The mechanism of transport involves the following steps:
1. **Binding of protons:** The transporter binds protons on one side of the membrane, typically the extracellular side. This binding event causes a conformational change in the transporter protein.
2. **Oligopeptide binding:** The conformational change facilitates the binding of oligopeptides on the same side of the membrane as the protons.
3. **Translocation:** The transporter undergoes another conformational change, moving the bound oligopeptides across the membrane to the opposite side.
4. **Proton release:** The transporter releases protons on the other side of the membrane, typically the intracellular side. This release restores the original conformation of the transporter, ready for another cycle.
The specificity of these transporters for oligopeptides varies depending on the transporter. Some transporters are highly specific for certain types of oligopeptides, while others exhibit broader substrate specificity.
These transporters play crucial roles in various physiological processes, including:
* **Nutrient uptake:** Transporting essential amino acids and peptides into cells.
* **Drug transport:** Mediating the uptake and efflux of various drugs.
* **Immune function:** Facilitating the transport of peptides involved in antigen presentation.
* **Cellular signaling:** Regulating the intracellular concentrations of signaling peptides.
Mutations or dysregulation of these transporters can lead to various diseases, including:
* **Malabsorption disorders:** Impaired nutrient absorption due to defects in peptide transport.
* **Drug resistance:** Altered drug uptake and efflux due to changes in transporter activity.
* **Immune dysfunction:** Compromised antigen presentation and immune responses.
In summary, proton-dependent oligopeptide secondary active transmembrane transporter activity is a vital process that plays a crucial role in various cellular functions, contributing to nutrient uptake, drug transport, immune responses, and cellular signaling.'
"
Protein | Definition | Taxonomy |
---|---|---|
Solute carrier family 15 member 1 | A solute carrier family 15 member 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P46059] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
aminolevulinic acid | 5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp. Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. | 4-oxo monocarboxylic acid; amino acid zwitterion; delta-amino acid | antineoplastic agent; dermatologic drug; Escherichia coli metabolite; human metabolite; mouse metabolite; photosensitizing agent; plant metabolite; prodrug; Saccharomyces cerevisiae metabolite |
5-aminovaleric acid | 5-aminopentanoic acid : A delta-amino acid comprising pentanoic acid with an amino substituent at C-5; a methylene homologue of gamma-aminobutyric acid (GABA) that is a weak GABA agonist. 5-aminovaleric acid: from red fox anal secretion; RN given refers to parent cpd | amino acid zwitterion; delta-amino acid; omega-amino fatty acid | human metabolite |
alanylalanine | alanylalanine: RN given refers to (DL)-isomer | dipeptide | |
cephaloridine | cefaloridine : A cephalosporin compound having pyridinium-1-ylmethyl and 2-thienylacetamido side-groups. A first-generation semisynthetic derivative of cephalosporin C. Cephaloridine: A cephalosporin antibiotic. | beta-lactam antibiotic allergen; cephalosporin; semisynthetic derivative | antibacterial drug |
floxuridine | floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. | nucleoside analogue; organofluorine compound; pyrimidine 2'-deoxyribonucleoside | antimetabolite; antineoplastic agent; antiviral drug; radiosensitizing agent |
penicillin g | benzylpenicillin : A penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group. Penicillin G: A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission. | penicillin; penicillin allergen | antibacterial drug; drug allergen; epitope |
cephalothin | cefalotin : A semisynthetic, first-generation cephalosporin antibiotic with acetoxymethyl and (2-thienylacetyl)nitrilo moieties at positions 3 and 7, respectively, of the core structure. Administered parenterally during surgery and to treat a wide spectrum of blood infections. Cephalothin: A cephalosporin antibiotic. | azabicycloalkene; beta-lactam antibiotic allergen; carboxylic acid; cephalosporin; semisynthetic derivative; thiophenes | antibacterial drug; antimicrobial agent |
levodopa | L-dopa : An optically active form of dopa having L-configuration. Used to treat the stiffness, tremors, spasms, and poor muscle control of Parkinson's disease Levodopa: The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. | amino acid zwitterion; dopa; L-tyrosine derivative; non-proteinogenic L-alpha-amino acid | allelochemical; antidyskinesia agent; antiparkinson drug; dopaminergic agent; hapten; human metabolite; mouse metabolite; neurotoxin; plant growth retardant; plant metabolite; prodrug |
cloxacillin | cloxacillin : A semisynthetic penicillin antibiotic carrying a 3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido group at position 6. Cloxacillin: A semi-synthetic antibiotic that is a chlorinated derivative of OXACILLIN. | penicillin; penicillin allergen; semisynthetic derivative | antibacterial agent; antibacterial drug |
oxacillin | oxacillin : A penicillin antibiotic carrying a 5-methyl-3-phenylisoxazole-4-carboxamide group at position 6beta. Oxacillin: An antibiotic similar to FLUCLOXACILLIN used in resistant staphylococci infections. | penicillin | antibacterial agent; antibacterial drug |
ampicillin | ampicillin : A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-phenylacetamido group. Ampicillin: Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. | beta-lactam antibiotic; penicillin; penicillin allergen | antibacterial drug |
penicillin v | Penicillin V: A broad-spectrum penicillin antibiotic used orally in the treatment of mild to moderate infections by susceptible gram-positive organisms. phenoxymethylpenicillin : A penicillin compound having a 6beta-(phenoxyacetyl)amino side-chain. | penicillin; penicillin allergen | |
aminopenicillanic acid | 6-aminopenicillanic acid : A penicillanic acid compound having a (6R)-amino substituent. The active nucleus common to all penicillins, it may be substituted at the 6-amino position to form the semisynthetic penicillins, resulting in a variety of antibacterial and pharmacologic characteristics. aminopenicillanic acid: RN given refers to parent cpd; structure | amino acid zwitterion; penicillanic acids | allergen |
glycyl-glycyl-glycine | glycyl-glycyl-glycine : A tripeptide in which three glycine units are linked via peptide bonds in a linear sequence. | tripeptide; tripeptide zwitterion | |
glycylglycine | dipeptide; dipeptide zwitterion | human metabolite | |
dicloxacillin | dicloxacillin : A penicillin that is 6-aminopenicillanic acid in which one of the amino hydrogens is replaced by a 3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]formyl group. Dicloxacillin: One of the PENICILLINS which is resistant to PENICILLINASE. | dichlorobenzene; penicillin | antibacterial drug |
cyclacillin | Cyclacillin: A cyclohexylamido analog of PENICILLANIC ACID. | penicillin | antibacterial drug |
floxacillin | Floxacillin: Antibiotic analog of CLOXACILLIN. flucloxacillin : A penicillin compound having a 6beta-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carboxamido] side-chain. | penicillin; penicillin allergen | antibacterial drug |
cephalexin | cephalexin : A semisynthetic first-generation cephalosporin antibiotic having methyl and beta-(2R)-2-amino-2-phenylacetamido groups at the 3- and 7- of the cephem skeleton, respectively. It is effective against both Gram-negative and Gram-positive organisms, and is used for treatment of infections of the skin, respiratory tract and urinary tract. Cephalexin: A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. | beta-lactam antibiotic allergen; cephalosporin; semisynthetic derivative | antibacterial drug |
cephapirin | cephapirin : A cephalosporin with acetoxymethyl and 2(pyridin-4-ylsulfanyl)acetamido substituents at positions 3 and 7, respectively, of the cephem skeleton. It is used (as its sodium salt) as an antibiotic, being effective against gram-negative and gram-positive organisms. Cephapirin: Cephalosporin antibiotic, partly plasma-bound, that is effective against gram-negative and gram-positive organisms. | cephalosporin | antibacterial drug |
cefazolin | cefazolin : A first-generation cephalosporin compound having [(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl and (1H-tetrazol-1-ylacetyl)amino side-groups at positions 3 and 7 respectively. Cefazolin: A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine. | beta-lactam antibiotic allergen; cephalosporin; tetrazoles; thiadiazoles | antibacterial drug |
amoxicillin | amoxicillin : A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-(4-hydroxyphenyl)acetamido group. Amoxicillin: A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration. | penicillin; penicillin allergen | antibacterial drug |
cephradine | cephradine : A first-generation cephalosporin antibiotic with a methyl substituent at position 3, and a (2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetamido substituent at position 7, of the cephem skeleton. Cephradine: A semi-synthetic cephalosporin antibiotic. | beta-lactam antibiotic allergen; cephalosporin | antibacterial drug |
methyldopa | alpha-methyl-L-dopa : A derivative of L-tyrosine having a methyl group at the alpha-position and an additional hydroxy group at the 3-position on the phenyl ring. Methyldopa: An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. | L-tyrosine derivative; non-proteinogenic L-alpha-amino acid | alpha-adrenergic agonist; antihypertensive agent; hapten; peripheral nervous system drug; sympatholytic agent |
cefmetazole | cefmetazole : A second-generation cephalosporin antibiotic having N(1)-methyltetrazol-5-ylthiomethyl, {[(cyanomethyl)sulfanyl]acetyl}amino and methoxy side-groups at positions 3, 7beta and 7alpha respectively of the parent cephem bicyclic structure. Cefmetazole: A semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. It has a high rate of efficacy in many types of infection and to date no severe side effects have been noted. | cephalosporin | antibacterial drug |
piperacillin | piperacillin : A penicillin in which the substituent at position 6 of the penam ring is a 2-[(4-ethyl-2,3-dioxopiperazin-1-yl)carboxamido]-2-phenylacetamido group. Piperacillin: Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics. | penicillin; penicillin allergen | antibacterial drug |
moxalactam | moxalactam : A broad-spectrum oxacephem antibiotic in which the oxazine ring is substituted with a tetrazolylthiomethyl group and the azetidinone ring carries methoxy and 2-carboxy-2-(4-hydroxyphenyl)acetamido substituents. Moxalactam: Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections. | cephalosporin; oxacephem | antibacterial drug |
cefadroxil anhydrous | cefadroxil : A cephalosporin bearing methyl and (2R)-2-amino-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. Cefadroxil: Long-acting, broad-spectrum, water-soluble, CEPHALEXIN derivative. | cephalosporin | antibacterial drug |
cefaclor anhydrous | cefaclor : A cephalosporin bearing chloro and (R)-2-amino-2-phenylacetamido groups at positions 3 and 7, respectively, of the cephem skeleton. Cefaclor: Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN. | cephalosporin | antibacterial drug; drug allergen |
tyrosyltyrosine | Tyr-Tyr : Tyrosyltyrosine in which each tyrosine residue has L-configuration. tyrosyltyrosine : A dipeptide comprising tyrosine with a tyrosyl residue attached to the alpha-nitrogen. tyrosyltyrosine: RN given refers to all-(L)-isomer | tyrosyltyrosine | Mycoplasma genitalium metabolite |
leucyl-glycyl-glycine | Leu-Gly-Gly : A tripeptide composed of one L-leucine and two glycine residues joined in sequence. leucyl-glycyl-glycine: RN given refers to (L-Leu)-isomer | tripeptide | metabolite |
leucylleucine | Leu-Leu : A dipeptide formed from two L-leucine residues. | dipeptide; L-aminoacyl-L-amino acid zwitterion | human metabolite; Mycoplasma genitalium metabolite |
tamiflu | phosphate salt | ||
leucyl-alanine | Leu-Ala : A dipeptide composed of L-leucine and L-alanine joined by a peptide linkage. | dipeptide | metabolite |
alanylproline | alanylproline: RN given refers to all (L)-isomer | dipeptide; dipeptide zwitterion | metabolite |
phenylalanylphenylalanylamide | |||
Trp-Trp | Trp-Trp : A dipeptide formed from two L-tryptophan residues. tryptophyltryptophan: an antigelation agent | dipeptide | Mycoplasma genitalium metabolite |
glycyltryptophan | Gly-Trp : A dipeptide formed from glycine and L-tryptophan residues. glycyltryptophan: RN given refers to (L)-isomer | dipeptide | metabolite |
glycyltyrosine | Gly-Tyr : A dipeptide composed of glycine and L-tyrosine joined by a peptide linkage. | dipeptide | metabolite |
glycylleucine | Gly-Leu : A dipeptide composed of glycine and L-leucine joined by a peptide linkage. | dipeptide; dipeptide zwitterion | metabolite |
alanyltyrosine | Ala-Tyr : A dipeptide composed of L-alanine and L-tyrosine joined by a peptide linkage. alanyltyrosine: tyrosine source; RN given refers to (L)-isomer | dipeptide | metabolite |
glycyl-l-phenylalanine | Gly-Phe : A dipeptide formed from glycine and L-phenylalanine residues. glycylphenylalanine: RN given refers to (DL)-isomer | dipeptide; dipeptide zwitterion | human metabolite; metabolite |
glycylsarcosine | glycylsarcosine : A dipeptide obtained by formal condensation of the carboxy group of glycine with the amino group of sarcosine. | dipeptide; dipeptide zwitterion | |
alanylphenylalanine | alanylphenylalanine: RN given refers to (L-Ala-L-PheAla)-isomer | dipeptide | metabolite |
prolyl-glycyl-glycine | prolyl-glycyl-glycine: structure given in first source | oligopeptide | |
tryptophylglycine | Trp-Gly : A dipeptide formed from L-tryptophan and glycine residues. | dipeptide | metabolite |
glycylaspartic acid | glycylaspartic acid: RN given refers to (L)-isomer | dipeptide | metabolite |
n-glycylglutamic acid | Gly-Glu : A dipeptide formed from glycyl and L-glutamic acid residues. N-glycylglutamic acid: RN given refers to (L)-isomer | dipeptide | metabolite |
histidylglycine | His-Gly : A dipeptide formed from L-histidine and glycine residues. histidylglycine: RN given refers to all (L)-isomer | dipeptide | metabolite |
histidinoalanine | histidinoalanine: cross-linking amino acid in calcified tissue collagen; RN given refers to (L)-isomer | dipeptide; dipeptide zwitterion | metabolite |
valylvaline | Val-Val : A dipeptide formed from two L-valine residues. valylvaline: RN given refers to (L)-isomer | dipeptide | Mycoplasma genitalium metabolite |
tyrosyl-glycyl-glycine | Tyr-Gly-Gly : A tripeptide composed of one L-tyrosine and two glycine residues joined in sequence. tyrosyl-glycyl-glycine: RN given refers to L-isomer; this may not be the same as IMREG-1 | tripeptide; tripeptide zwitterion | metabolite |
glycyl-leucyl-phenylalanine | glycyl-leucyl-phenylalanine: an immunostimulatory peptide; RN given refer to all (L)-isomer | oligopeptide | |
lysyllysine | Lys-Lys : A dipeptide formed from two L-lysine residues. lysyllysine: RN given refers to (L-Lys)-isomer | dipeptide | Mycoplasma genitalium metabolite |
alanylglutamic acid | alanylglutamic acid: RN given refers to (L)-isomer L-alanyl-L-glutamic acid : A dipeptide consisting of L-glutamic acid having an L-alanyl attached to its alpha-amino group | dipeptide | |
prolylarginine | Pro-Arg : A dipeptide formed from L-proline and L-arginine residues. prolylarginine: fragment of tuftsin peptide with analgesic action; RN given refers to all L-isomer | dipeptide | metabolite |
aspartylglycine | Asp-Gly : A dipeptide composed of L-aspartic acid and glycine joined by a peptide linkage. | dipeptide | metabolite |
arginylarginine | Arg-Arg : A dipeptide formed from two L-arginine residues. | dipeptide | Mycoplasma genitalium metabolite |
prolyl-tyrosine | Pro-Tyr : A dipeptide formed from L-proline and L-tyrosine residues. prolyl-tyrosine: structure given in first source | dipeptide | metabolite |
n-valyltryptophan | N-valyltryptophan: RN given refers to (L)-isomer | peptide | |
prolylglutamic acid | Pro-Glu : A dipeptide formed from L-proline and L-glutamic acid residues. | dipeptide | metabolite |
cysteinylglycine | cysteinylglycine: RN given refers to (L)-isomer; RN for cpd without isomeric designation not in Chemlne 7/13/83 L-cysteinylglycine : A dipeptide consisting of glycine having an L-cysteinyl attached to its alpha-amino group. It is an intermediate metabolite in glutathione metabolism. | dipeptide; dipeptide zwitterion | Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite |
glutamyl-glutamic acid | Glu-Glu : A dipeptide composed of two L-glutamic acid units joined by a peptide linkage. glutamyl-glutamic acid: RN given for (L,L)-isomer | dipeptide | Mycoplasma genitalium metabolite |
cefoxitin | cefoxitin : A semisynthetic cephamycin antibiotic which, in addition to the methoxy group at the 7alpha position, has 2-thienylacetamido and carbamoyloxymethyl side-groups. It is resistant to beta-lactamase. Cefoxitin: A semisynthetic cephamycin antibiotic resistant to beta-lactamase. | beta-lactam antibiotic allergen; cephalosporin; cephamycin; semisynthetic derivative | antibacterial drug |
7-aminocephalosporanic acid | 7beta-aminocephalosporanic acid : The alpha,beta-unsaturated monocarboxylic acid that is the active nucleus for the synthesis of cephalosporins and intermediates. | alpha,beta-unsaturated monocarboxylic acid; amino acid zwitterion | |
cefamandole | cefamandole : A cephalosporin compound having (R)-mandelamido and N-methylthiotetrazole side-groups. Cefamandole: Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate. | cephalosporin; semisynthetic derivative | antibacterial drug |
aspartyl-aspartic acid | Asp-Asp : A dipeptide formed from two L-aspartic acid units. aspartyl-aspartic acid: do not confuse with cyclo(Asp-Asp) | dipeptide | Mycoplasma genitalium metabolite |
cefsulodin | cefsulodin : A pyridinium-substituted semi-synthetic, broad-spectrum, cephalosporin antibiotic. Cefsulodin: A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients. | cephalosporin; organosulfonic acid; primary carboxamide | antibacterial drug |
n-glycylalanine | Gly-Ala : A dipeptide formed from glycine and L-alanine residues. | dipeptide | metabolite |
glycylproline | Gly-Pro : A dipeptide consisting of L-proline having a glycyl residue attached to its alpha-amino group. | dipeptide; dipeptide zwitterion | metabolite |
glycyllysine | Gly-Lys : A dipeptide formed from glycine and L-lysine residues. glycyllysine: RN given refers to (L)-isomer | dipeptide | metabolite |
trimethionine | oligopeptide | ||
seryl-proline | Ser-Pro : A dipeptide formed from L-serine and L-proline residues. | dipeptide | metabolite |
7432 s | ceftibuten : A third-generation cephalosporin antibiotic with a [(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino substituent at the 7 position of the cephem skeleton. An orally-administered agent, ceftibuten is used as the dihydrate to treat urinary-tract and respiratory-tract infections. Ceftibuten: A cephalosporin antibacterial agent that is used in the treatment of infections, including urinary-tract and respiratory-tract infections. | cephalosporin; dicarboxylic acid | antibacterial drug |
cefodizime | cefodizime : A cephalosporin compound having 5-(carboxymethyl)-4-methyl-1,3-thiazol-2-yl]sulfanyl}methyl and [2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino side groups located at positions 3 and 7 respectively. cefodizime: RN given refers to (6R-(6alpha,7beta(Z)))-isomer | 1,3-thiazoles; cephalosporin; oxime O-ether | antibacterial drug; EC 1.14.18.1 (tyrosinase) inhibitor |
cefixime | cephalosporin | antibacterial drug; drug allergen | |
enalapril | enalapril : A dicarboxylic acid monoester that is ethyl 4-phenylbutanoate in which a hydrogen alpha to the carboxy group is substituted by the amino group of L-alanyl-L-proline (S-configuration). Enalapril: An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE. | dicarboxylic acid monoester; dipeptide | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; geroprotector; prodrug |
alanyl-alanyl-alanine | Ala-Ala-Ala : A tripeptide composed of three L-alanine units joined by peptide linkages. alanyl-alanyl-alanine: RN given refers to all (L)-isomer | tripeptide | metabolite |
cefuroxime | 3-(carbamoyloxymethyl)cephalosporin; furans; oxime O-ether | drug allergen | |
ceftriaxone | 1,2,4-triazines; 1,3-thiazoles; cephalosporin; oxime O-ether | antibacterial drug; drug allergen; EC 3.5.2.6 (beta-lactamase) inhibitor | |
cefepime | cefepime : A cephalosporin bearing (1-methylpyrrolidinium-1-yl)methyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. Cefepime: A fourth-generation cephalosporin antibacterial agent that is used in the treatment of infections, including those of the abdomen, urinary tract, respiratory tract, and skin. It is effective against PSEUDOMONAS AERUGINOSA and may also be used in the empiric treatment of FEBRILE NEUTROPENIA. | cephalosporin; oxime O-ether | antibacterial drug |
hr 810 | cefpirome : A fourth-generation cephalosporin antibiotic having 6,7-dihydro-5H-cyclopenta[b]pyridinium-1-ylmethyl and [(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino side groups located at positions 3 and 7 respectively. cefpirome: structure in first source | cephalosporin; cyclopentapyridine | |
ceftazidime | cephalosporin; oxime O-ether | antibacterial drug; drug allergen; EC 2.4.1.129 (peptidoglycan glycosyltransferase) inhibitor | |
alanylalanine | L-alanyl-L-alanine : A dipeptide consisting of two L-alanine units joined by a peptide linkage. | dipeptide; dipeptide zwitterion | Mycoplasma genitalium metabolite |
tyrosyl-alanyl-glycine | tyrosyl-alanyl-glycine: RN given refers to unlabeled (L-Tyr-D-Ala)-isomer | ||
phenylalanylalanine | Phe-Ala : A dipeptide formed from L-phenylalanine and L-alanine residues. phenylalanylalanine: RN given refers to (L)-isomer | dipeptide; dipeptide zwitterion | metabolite |
acetylalanylalanine | acetylalanylalanine: RN given refers to (D)-isomer | ||
alpha-aspartylalanine | alpha-aspartylalanine: found in pig brain Asp-Ala : A dipeptide formed from L-alpha-aspartyl and L-valine residues. | dipeptide | metabolite |
alanyltyrosine | Tyr-Ala : A dipeptide formed from L-tyrosine and L-alanine residues. | dipeptide | metabolite |
cefotaxime | cefotaxime : A cephalosporin compound having acetoxymethyl and [2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino side groups. Cefotaxime: Semisynthetic broad-spectrum cephalosporin. | 1,3-thiazoles; cephalosporin; oxime O-ether | antibacterial drug; drug allergen |
cefpodoxime | carboxylic acid; cephalosporin | antibacterial drug | |
prolylglycine | L-prolylglycine : A dipeptide consisting of glycine having an L-prolyl group attached to its alpha-amino nitrogen. prolylglycine: RN given refers to (L)-isomer | dipeptide; dipeptide zwitterion | |
aspartyllysine | Asp-Lys : A dipeptide formed from L-alpha-aspartyl and L-lysine residues. aspartyllysine: from feces of axenic mice | dipeptide | metabolite |
arginyllysine | Arg-Lys : A dipeptide formed from L-arginyl and L-leucine residues. | dipeptide | metabolite |
methampicillin | metampicillin : A penicillin compound having a 6beta-(2R)-2-(methylideneamino)-2-phenylacetamido side-group. methampicillin: RN given refers to parent cpd(2S-(2alpha,5alpha,6beta(S*)))-isomer | penicillin; penicillin allergen | |
phenylalanylglycine | Phe-Gly : A dipeptide formed from L-phenylalanine and glycine residues. phenylalanylglycine: RN given refers to (DL)-isomer | dipeptide | metabolite |
glutamylalanine | Glu-Ala : A dipeptide formed from L-alpha-glutamyl and L-alanine residues. | dipeptide | metabolite |
phenylalanylphenylalanine | Phe-Phe : A dipeptide formed from two L-phenylalanine residues. | dipeptide; L-aminoacyl-L-amino acid zwitterion | human blood serum metabolite; Mycoplasma genitalium metabolite |
histidylhistidine | histidylhistidine: RN given for L-,L-isomer | dipeptide | Mycoplasma genitalium metabolite |
phenylalanyl-valine | Val-Phe : A dipeptide formed from L-valine and L-phenylalanine residues. | dipeptide | metabolite |
alanylglycine | dipeptide; dipeptide zwitterion | metabolite | |
valyltyrosine | Val-Tyr : A dipeptide formed from L-valine and L-tyrosine residues. valyltyrosine: from sardine muscle hydrolyzate | dipeptide | metabolite |
lysylglutamic acid | Lys-Glu : A dipeptide formed from L-lysine and L-glutamic acid residues. lysylglutamic acid: a geroprotective agent | dipeptide | metabolite |
Ala-Lys | Ala-Lys : A dipeptide obtained by formal condensation of the carboxy group of L-alanine with the alpha-amino group of L-lysine. | dipeptide | marine metabolite |
valyl-valyl-valine | peptide | ||
phenylalanylproline | Phe-Pro : A dipeptide formed from L-phenylalanine and L-proline residues. | dipeptide | metabolite |
lysylglycine | Lys-Gly : A dipeptide formed from L-lysine and glycine residues. lysylglycine: structure in first source | dipeptide | metabolite |
glycylhistidine | Gly-His : A dipeptide composed of glycine and L-histidine joined by a peptide linkage. glycylhistidine: RN given refers to (L)-isomer | dipeptide; dipeptide zwitterion | metabolite |
isoleucyl-tyrosine | Ile-Tyr : A dipeptide formed from L-isoleucine and L-tyrosine residues. isoleucyl-tyrosine: a dipeptide with antihypertensive effect | dipeptide | metabolite |
prolyl-serine | Pro-Ser : A dipeptide formed from L-proline and L-serine residues. | dipeptide | metabolite |
jbp 485 | JBP 485: has antihepatitis activity | ||
valyl-prolyl-proline | Val-Pro-Pro : A tripeptide composed of L-valine and two L-proline units joined by peptide linkages. | tripeptide | metabolite |
prolylvaline | Val-Pro : A dipeptide formed from L-valine and L-proline residues. | dipeptide | metabolite |
isoleucyl-prolyl-proline | oligopeptide | ||
isoleucyl-valyl-tyrosine | oligopeptide | ||
prolyl-proline | Pro-Pro : A dipeptide formed from two L-proline residues. | dipeptide | human urinary metabolite; Mycoplasma genitalium metabolite |
valtrex | organic molecular entity | ||
valacyclovir | Valacyclovir: A prodrug of acyclovir that is used in the treatment of HERPES ZOSTER and HERPES SIMPLEX VIRUS INFECTION of the skin and mucous membranes, including GENITAL HERPES. | L-valyl ester | antiviral drug |